Osterweis Capital Management Inc Alx Oncology Holdings Inc Transaction History

Osterweis Capital Management Inc

  • $1.67 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$21.49 - $74.4 $1.45 Million - $5.02 Million
-67,535 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$52.51 - $80.91 $349,716 - $538,860
6,660 Added 10.94%
67,535 $4.99 Million
Q2 2021

Aug 16, 2021
SELL
$52.2 - $75.23 $770,994 - $1.11 Million
-14,770 Reduced 19.53%
60,875 $3.33 Million
Q1 2021

May 14, 2021
BUY
$62.84 - $87.68 $4.75 Million - $6.63 Million
75,645 New
75,645 $5.58 Million

Others Institutions Holding ALXO

# of Institutions
101
Shares Held
39.7M
Call Options Held
134K
Put Options Held
17.4K
View Full List

About ALX ONCOLOGY HOLDINGS INC

ALXO Quotes by TradingView
  • Ticker ALXO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,747,100
  • Market Cap $66M
  • Description
  • ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...
More about ALXO
Track This Portfolio

Track Osterweis Capital Management Inc Portfolio

Follow Osterweis Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Osterweis Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Osterweis Capital Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email